{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:40:03Z","timestamp":1792813203230,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.leukres.2012.12.001","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T11:04:33Z","timestamp":1358507073000},"page":"396-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The significance of MUM1\/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases"],"prefix":"10.1016","volume":"37","author":[{"given":"Tugce","family":"Kiran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuyan","family":"Demirkesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candan","family":"Eker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakki","family":"Kumusoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nukhet","family":"Tuzuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (3)","key":"10.1016\/j.leukres.2012.12.001_bib0005","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"issue":"March (6)","key":"10.1016\/j.leukres.2012.12.001_bib0010","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V95.6.2084","article-title":"A monoclonal antibody (MUM1p) detects expression of the MUM1\/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells","volume":"95","author":"Falini","year":"2000","journal-title":"Blood"},{"issue":"April (4)","key":"10.1016\/j.leukres.2012.12.001_bib0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"issue":"March (3)","key":"10.1016\/j.leukres.2012.12.001_bib0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"January (3)","key":"10.1016\/j.leukres.2012.12.001_bib0025","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7) (p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.12.001_bib0030","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.leukres.2012.12.001_bib0035","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1365-2133.2008.08566.x","article-title":"MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"158","author":"Kempf","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.leukres.2012.12.001_bib0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.humpath.2007.08.013","article-title":"The expression of MUM1 in cutaneou T-cell lymphoproliferative disorders","volume":"39","author":"Wasco","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.leukres.2012.12.001_bib0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2133.2009.09147.x","article-title":"Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1 BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders","volume":"161","author":"Benner","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.leukres.2012.12.001_bib0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2133.2008.09002.x","article-title":"MUM1 expression does not differentiate primary cutaneous anaplastic large-cell lymphoma and lymphomatoid papulosis","volume":"160","author":"Hernandez-Machin","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.leukres.2012.12.001_bib0055","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/1078-0432.CCR-08-1845","article-title":"IRF4: immunity malignancy! therapy?","volume":"15","author":"Shaffer","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612004584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612004584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:57:53Z","timestamp":1758934673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212612004584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0145212612004584"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2012.12.001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The significance of MUM1\/IRF4 protein expression and IRF4 translocation of CD30(+) cutaneous T-cell lymphoproliferative disorders: A study of 53 cases","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2012.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}